NCT07267468

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of an mHealth intervention as a complement to usual clinical practice for the improvement and recovery of dysphagia in patients who have suffered a stroke. The main question it aims to answer is: \- Does the mHealth intervention improve the recovery of dysphagia in post-stroke patients compared to usual care alone? Researchers will compare patients receiving the mHealth intervention plus usual care to see if the combined approach leads to better dysphagia outcomes, reduced negative consequences (e.g., malnutrition, pneumonia), and improved quality of life compared to usual care alone. Participants will be recruited and:

  • Receive a diagnosis and usual care for post-stroke dysphagia.
  • Be assigned to either the mHealth intervention group (using a smartphone/tablet app for information and follow-up) or the control group (usual care only).
  • Be followed up to assess dysphagia recovery, reduction in negative outcomes (like aspiration pneumonia, dehydration), and changes in quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
7mo left

Started Jan 2026

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Jan 2026Nov 2026

First Submitted

Initial submission to the registry

November 13, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

November 13, 2025

Last Update Submit

January 30, 2026

Conditions

Keywords

StrokeDeglutition DisordersPneumonia, AspirationNutritionRehabilitationmHealth

Outcome Measures

Primary Outcomes (4)

  • Dysphagia Improvement and Recovery

    Dysphagia Improvement and Recovery. Dichotomous qualitative variable: Yes, No.

    Day 1, 3 months, 6 months, and 9 months

  • Type of texture

    Type of texture and volume the patient follows in their habitual diet. Categorical qualitative variable: Liquid, Nectar, Honey, Pudding.

    Day 1, 3 months, 6 months, and 9 months

  • Volume allowed when swallowing

    Volume the patient follows in their habitual diet. Categorical qualitative variable: 5 mL, 10 mL, and 20 mL

    Day 1, 3 months, 6 months, and 9 months

  • Acceptable viscosity when swallowing

    Measured using the Volume-Viscosity Swallow Test (V-VST). The test is performed using three different viscosities (thin liquid, nectar-thick, and pudding-thick) and three different volumes 3 ml, 5 ml, and 20 ml) to determine the volume-viscosity combination that is safest and most efficient for the patient. It is a clinical diagnostic tool used to evaluate the efficacy and safety of a patient's swallowing function (deglutition) by systematically challenging it with a controlled set of liquid volumes and viscosities. It contains two main safety and efficiency markers. For the Safety Scale (aspiration/penetration), levels typically range from a minimum of 0 (no safety issues detected) to a maximum of 2 (indicating severe issues like persistent cough or desaturation). Similarly, the Efficiency Scale might range from Level 0 (efficient swallow) to Level 1 (reduced efficiency).

    Day 1, 3 months, 6 months, and 9 months

Secondary Outcomes (16)

  • Perceived quality of life

    Day 1, 3 months, 6 months, and 9 months

  • Weight

    Day 1, 3 months, 6 months, and 9 months

  • Height

    Day 1, 3 months, 6 months, and 9 months

  • Body Mass Index

    Day 1, 3 months, 6 months, and 9 months

  • Anthropometric variables

    Day 1, 3 months, 6 months, and 9 months

  • +11 more secondary outcomes

Other Outcomes (12)

  • Sex

    Day 1

  • Age

    Day 1

  • Presence of caregiver

    Day 1

  • +9 more other outcomes

Study Arms (2)

mHealth Group

EXPERIMENTAL

This group will receive the mHealth intervention via the mobile application "DegluApp".

Other: mHealth intervention

No intervention Group

NO INTERVENTION

This group will perform conventional care according to the healthcare centers' protocols.

Interventions

The intervention consists of using the validated mobile application "DegluApp", which contains recommendations and exercises related to nutrition, physical activity, rehabilitation, warning signs, and games pertinent to the daily life of a person with post-stroke dysphagia.

mHealth Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged 18 years or older.
  • Patients with any degree of impairment in swallowing/oropharyngeal dysphagia to liquids following a stroke (ACV).

You may not qualify if:

  • Hospitalized patients presenting any type of visual barrier.
  • Patients in terminal palliative care.
  • Patients in the final days of life phase.
  • Patients with severe cognitive impairment.
  • Patients with a language barrier regarding the use of the App.
  • Subject Withdrawal Criteria:
  • Revocation of consent. In this case, the subject will exit the study and will not be replaced by another subject, being considered a "loss".
  • Lack of adherence to the prescribed training plan exceeding 20% of the scheduled sessions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing. Punta Europa University Hospital

Algeciras, Cadiz, 11207, Spain

RECRUITING

Related Publications (23)

  • Hernandez G, Garin O, Dima AL, Pont A, Marti Pastor M, Alonso J, Van Ganse E, Laforest L, de Bruin M, Mayoral K, Serra-Sutton V, Ferrer M; ASTRO-LAB Group. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study. J Med Internet Res. 2019 Jan 23;21(1):e10178. doi: 10.2196/10178.

    PMID: 30672744BACKGROUND
  • Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.

    PMID: 7203086BACKGROUND
  • Lim ML, Yong BYP, Mar MQM, Ang SY, Chan MM, Lam M, Chong NCJ, Lopez V. Caring for patients on home enteral nutrition: Reported complications by home carers and perspectives of community nurses. J Clin Nurs. 2018 Jul;27(13-14):2825-2835. doi: 10.1111/jocn.14347. Epub 2018 Apr 22.

    PMID: 29518266BACKGROUND
  • Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, Albarede JL. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999 Feb;15(2):116-22. doi: 10.1016/s0899-9007(98)00171-3.

    PMID: 9990575BACKGROUND
  • Sanchez-Rodriguez D, Marco E, Davalos-Yerovi V, Lopez-Escobar J, Messaggi-Sartor M, Barrera C, Ronquillo-Moreno N, Vazquez-Ibar O, Calle A, Inzitari M, Piotrowicz K, Duran X, Escalada F, Muniesa JM, Duarte E. Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People. J Nutr Health Aging. 2019;23(6):518-524. doi: 10.1007/s12603-019-1204-z.

    PMID: 31233072BACKGROUND
  • Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

    PMID: 11253156BACKGROUND
  • Guillen-Sola A, Marco E, Martinez-Orfila J, Donaire Mejias MF, Depolo Passalacqua M, Duarte E, Escalada F. Usefulness of the volume-viscosity swallow test for screening dysphagia in subacute stroke patients in rehabilitation income. NeuroRehabilitation. 2013;33(4):631-8. doi: 10.3233/NRE-130997.

    PMID: 24018371BACKGROUND
  • Ortega-Martin ME, Lucena-Anton D, Luque-Moreno C, Heredia-Rizo AM, Moral-Munoz JA. [Commercial mobile applications in the therapeutic approach to stroke: Review in main application repositories and scientific evidence]. Rev Esp Salud Publica. 2019 Jun 12;93:e201906035. Spanish.

    PMID: 31204385BACKGROUND
  • Teasell R, Salbach NM, Foley N, Mountain A, Cameron JI, Jong A, Acerra NE, Bastasi D, Carter SL, Fung J, Halabi ML, Iruthayarajah J, Harris J, Kim E, Noland A, Pooyania S, Rochette A, Stack BD, Symcox E, Timpson D, Varghese S, Verrilli S, Gubitz G, Casaubon LK, Dowlatshahi D, Lindsay MP. Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke. Part One: Rehabilitation and Recovery Following Stroke; 6th Edition Update 2019. Int J Stroke. 2020 Oct;15(7):763-788. doi: 10.1177/1747493019897843. Epub 2020 Jan 27.

    PMID: 31983296BACKGROUND
  • Marin S, Serra-Prat M, Ortega O, Audouard Fericgla M, Valls J, Palomera E, Cunillera R, Palomeras E, Ibanez JM, Clave P. Healthcare costs of post-stroke oropharyngeal dysphagia and its complications: malnutrition and respiratory infections. Eur J Neurol. 2021 Nov;28(11):3670-3681. doi: 10.1111/ene.14998. Epub 2021 Jul 27.

    PMID: 34176195BACKGROUND
  • Kim DY, Park HS, Park SW, Kim JH. The impact of dysphagia on quality of life in stroke patients. Medicine (Baltimore). 2020 Aug 21;99(34):e21795. doi: 10.1097/MD.0000000000021795.

    PMID: 32846813BACKGROUND
  • Bath PM, Lee HS, Everton LF. Swallowing therapy for dysphagia in acute and subacute stroke. Cochrane Database Syst Rev. 2018 Oct 30;10(10):CD000323. doi: 10.1002/14651858.CD000323.pub3.

    PMID: 30376602BACKGROUND
  • Krajczy E, Krajczy M, Luniewski J, Bogacz K, Szczegielniak J. Assessment of the effects of dysphagia therapy in patients in the early post-stroke period: a randomised controlled trial. Neurol Neurochir Pol. 2019;53(6):428-434. doi: 10.5603/PJNNS.a2019.0053. Epub 2019 Nov 14.

    PMID: 31724147BACKGROUND
  • Sura L, Madhavan A, Carnaby G, Crary MA. Dysphagia in the elderly: management and nutritional considerations. Clin Interv Aging. 2012;7:287-98. doi: 10.2147/CIA.S23404. Epub 2012 Jul 30.

    PMID: 22956864BACKGROUND
  • Pierpoint M, Pillay M. Post-stroke dysphagia: An exploration of initial identification and management performed by nurses and doctors. S Afr J Commun Disord. 2020 May 28;67(1):e1-e13. doi: 10.4102/sajcd.v67i1.625.

    PMID: 32501033BACKGROUND
  • Shimizu A, Fujishima I, Maeda K, Murotani K, Ohno T, Nomoto A, Nagami S, Nagano A, Sato K, Ueshima J, Inoue T, Shimizu M, Ishida Y, Kayashita J, Suenaga M, Mori N. Delayed Dysphagia May Be Sarcopenic Dysphagia in Patients After Stroke. J Am Med Dir Assoc. 2021 Dec;22(12):2527-2533.e1. doi: 10.1016/j.jamda.2021.07.013. Epub 2021 Aug 11.

    PMID: 34389335BACKGROUND
  • Benfield JK, Wilkinson G, Everton LF, Bath PM, England TJ. Diagnostic accuracy of the Dysphagia Trained Nurse Assessment tool in acute stroke. Eur J Neurol. 2021 Aug;28(8):2766-2774. doi: 10.1111/ene.14900. Epub 2021 May 29.

    PMID: 33960075BACKGROUND
  • Marin S, Serra-Prat M, Ortega O, Clave P. Healthcare-related cost of oropharyngeal dysphagia and its complications pneumonia and malnutrition after stroke: a systematic review. BMJ Open. 2020 Aug 11;10(8):e031629. doi: 10.1136/bmjopen-2019-031629.

    PMID: 32784251BACKGROUND
  • Li C, Qiu C, Shi Y, Yang T, Shao X, Zheng D. Experiences and perceptions of stroke patients living with dysphagia: A qualitative meta-synthesis. J Clin Nurs. 2022 Apr;31(7-8):820-831. doi: 10.1111/jocn.15995. Epub 2021 Aug 8.

    PMID: 34369025BACKGROUND
  • Dziewas R, Michou E, Trapl-Grundschober M, Lal A, Arsava EM, Bath PM, Clave P, Glahn J, Hamdy S, Pownall S, Schindler A, Walshe M, Wirth R, Wright D, Verin E. European Stroke Organisation and European Society for Swallowing Disorders guideline for the diagnosis and treatment of post-stroke dysphagia. Eur Stroke J. 2021 Sep;6(3):LXXXIX-CXV. doi: 10.1177/23969873211039721. Epub 2021 Oct 13.

    PMID: 34746431BACKGROUND
  • Jones CA, Colletti CM, Ding MC. Post-stroke Dysphagia: Recent Insights and Unanswered Questions. Curr Neurol Neurosci Rep. 2020 Nov 2;20(12):61. doi: 10.1007/s11910-020-01081-z.

    PMID: 33136216BACKGROUND
  • Fang WJ, Zheng F, Zhang LZ, Wang WH, Yu CC, Shao J, Wu YJ. Research progress of clinical intervention and nursing for patients with post-stroke dysphagia. Neurol Sci. 2022 Oct;43(10):5875-5884. doi: 10.1007/s10072-022-06191-9. Epub 2022 Jun 4.

    PMID: 35661279BACKGROUND
  • King D, Wittenberg R, Patel A, Quayyum Z, Berdunov V, Knapp M. The future incidence, prevalence and costs of stroke in the UK. Age Ageing. 2020 Feb 27;49(2):277-282. doi: 10.1093/ageing/afz163.

    PMID: 31957781BACKGROUND

MeSH Terms

Conditions

StrokeDeglutition DisordersPneumonia, Aspiration

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesPneumoniaRespiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Eduardo Sánchez-Sánchez, Ph.D.

    University of Cadiz. Andalusian Healthcare Service

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eduardo Sánchez-Sánchez, Ph.D.

CONTACT

Antonio-Jesús Marín-Paz, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The random allocation of participants will also be blinded to the researchers.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Collaborator Investigator

Study Record Dates

First Submitted

November 13, 2025

First Posted

December 5, 2025

Study Start

January 30, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The data obtained in the study will be anonymized and will be published collectively in a database at the time of the publication of the research results.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Study Protocol: October 2025. Informed Consent Form: October-November 2025. Statistical Analysis Plan: October-November 2025. Database of results: At the time of the publication of the research results.
Access Criteria
All data will be incorporated in open access both into this research protocol and at the time of the publication of the research results.

Locations